Fol. Biol. 2019, 65, 43-52
https://doi.org/10.14712/fb2019065010043
Trichostatin A Inhibits Rhabdomyosarcoma Proliferation and Induces Differentiation through MyomiR Reactivation
Crossref Cited-by Linking
- Selim Omar, Song Clara, Kumar Amy, Phelan Rebecca, Singh Arun, Federman Noah: A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma. Front. Oncol. 2023, 13. <https://doi.org/10.3389/fonc.2023.1244035>
- Tomasiak Patrycja, Janisiak Joanna, Rogi\u0144ska Dorota, Peru\u017cy\u0144ska Magdalena, Machali\u0144ski Bogus\u0142aw, Tarnowski Maciej: Garcinol and Anacardic Acid, Natural Inhibitors of Histone Acetyltransferases, Inhibit Rhabdomyosarcoma Growth and Proliferation. Molecules 2023, 28, 5292. <https://doi.org/10.3390/molecules28145292>
- Bouyahya Abdelhakim, El Omari Nasreddine, Bakha Mohamed, Aanniz Tarik, El Menyiy Naoual, El Hachlafi Naoufal, El Baaboua Aicha, El-Shazly Mohamed, Alshahrani Mohammed Merae, Al Awadh Ahmed Abdullah, Lee Learn-Han, Benali Taoufiq, Mubarak Mohammad S.: Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review. Pharmaceuticals 2022, 15, 1235. <https://doi.org/10.3390/ph15101235>
- Di Fede Elisabetta, Ottaviano Emerenziana, Grazioli Paolo, Ceccarani Camilla, Galeone Antonio, Parodi Chiara, Colombo Elisa Adele, Bassanini Giulia, Fazio Grazia, Severgnini Marco, Milani Donatella, Verduci Elvira, Vaccari Thomas, Massa Valentina, Borghi Elisa, Gervasini Cristina: Insights into the Role of the Microbiota and of Short-Chain Fatty Acids in Rubinstein\u2013Taybi Syndrome. IJMS 2021, 22, 3621. <https://doi.org/10.3390/ijms22073621>
- Janisiak Joanna, Kopytko Patrycja, Tkacz Marta, Rogi\u0144ska Dorota, Peru\u017cy\u0144ska Magdalena, Machali\u0144ski Bogus\u0142aw, Pawlik Andrzej, Tarnowski Maciej: Protein Arginine Methyltransferase (PRMT) Inhibitors\u2014AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures. IJMS 2021, 22, 8023. <https://doi.org/10.3390/ijms22158023>
- Pacenta Holly L., Allen-Rhoades Wendy, Langenau David, Houghton Peter J., Keller Charles, Heske Christine M., Deel Michael D., Linardic Corinne M., Shern Jack F., Stewart Elizabeth, Turpin Brian, Harrison Douglas J., Khan Javed, Mascarenhas Leo, Skapek Stephen X., Meyer William H., Hawkins Douglas S., Chen Eleanor Y., Amatruda James F., Hingorani Pooja, Laetsch Theodore W.: Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children\u2019s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force. JCM 2021, 10, 1416. <https://doi.org/10.3390/jcm10071416>